Nonstructured Treatment Interruptions Are Associated With Higher Human Immunodeficiency Virus Reservoir Size Measured by Intact Proviral DNA Assay in People Who Inject Drugs

被引:7
作者
Kirk, Gregory D. [1 ,2 ]
Astemborski, Jacqueline [1 ]
Mehta, Shruti H. [1 ]
Ritter, Kristen D. [3 ]
Laird, Gregory M. [3 ]
Bordi, Rebeka [4 ]
Sekaly, Rafick [4 ]
Siliciano, Janet D. [2 ]
Siliciano, Robert F. [2 ,5 ]
机构
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
[2] Johns Hopkins Univ, Dept Med, Sch Med, Baltimore, MD 21205 USA
[3] Accelevir Diagnost, Baltimore, MD USA
[4] Case Western Reserve Univ, Dept Pathol, Cleveland, OH 44106 USA
[5] Howard Hughes Med Inst, Baltimore, MD USA
关键词
HIV-1 latent reservoir; HIV-1 viral suppression; people who inject drugs; PWID; antiretroviral therapy; ART; nonstructured treatment interruption; NTI; CD4(+) T-CELLS; LATENT RESERVOIR; HIV-1; PROVIRUSES; IDENTIFICATION; SUPPRESSION; STABILITY; INFECTION; PROVIDES; PROTEIN; CARE;
D O I
10.1093/infdis/jiaa634
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The latent reservoir for human immunodeficiency virus type 1 (HIV-1) in CD4(+)T cells is a major barrier to cure. HIV-1-infected persons who inject drugs (PWID) often struggle to maintain suppression of viremia and experience nonstructured treatment interruptions (NTIs). The effects of injecting drugs or NTIs on the reservoir are unclear. Using the intact proviral DNA assay, we found no apparent effect of heroin or cocaine use on reservoir size. However, we found significantly larger reservoirs in those with frequent NTIs or a shorter interval from last detectable HIV RNA measurement. These results have important implications for inclusion of PWID in HIV-1 cure studies.
引用
收藏
页码:1905 / 1913
页数:9
相关论文
共 39 条
[1]   Administration of vorinostat disrupts HIV-1 latency in patients on antiretroviral therapy [J].
Archin, N. M. ;
Liberty, A. L. ;
Kashuba, A. D. ;
Choudhary, S. K. ;
Kuruc, J. D. ;
Crooks, A. M. ;
Parker, D. C. ;
Anderson, E. M. ;
Kearney, M. F. ;
Strain, M. C. ;
Richman, D. D. ;
Hudgens, M. G. ;
Bosch, R. J. ;
Coffin, J. M. ;
Eron, J. J. ;
Hazuda, D. J. ;
Margolis, D. M. .
NATURE, 2012, 487 (7408) :482-U1650
[2]   Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection [J].
Blankson, JN ;
Finzi, D ;
Pierson, TC ;
Sabundayo, BP ;
Chadwick, K ;
Margolick, JB ;
Quinn, TC ;
Siliciano, RF .
JOURNAL OF INFECTIOUS DISEASES, 2000, 182 (06) :1636-1642
[3]   A quantitative approach for measuring the reservoir of latent HIV-1 proviruses [J].
Bruner, Katherine M. ;
Wang, Zheng ;
Simonetti, Francesco R. ;
Bender, Alexandra M. ;
Kwon, Kyungyoon J. ;
Sengupta, Srona ;
Fray, Emily J. ;
Beg, Subul A. ;
Antar, Annukka A. R. ;
Jenike, Katharine M. ;
Bertagnolli, Lynn N. ;
Capoferri, Adam A. ;
Kufera, Joshua T. ;
Timmons, Andrew ;
Nobles, Christopher ;
Gregg, John ;
Wada, Nikolas ;
Ho, Ya-Chi ;
Zhang, Hao ;
Margolick, Joseph B. ;
Blankson, Joel N. ;
Deeks, Steven G. ;
Bushman, Frederic D. ;
Siliciano, Janet D. ;
Laird, Gregory M. ;
Siliciano, Robert F. .
NATURE, 2019, 566 (7742) :120-+
[4]   Defective proviruses rapidly accumulate during acute HIV-1 infection [J].
Bruner, Katherine M. ;
Murray, Alexandra J. ;
Pollack, Ross A. ;
Soliman, Mary G. ;
Laskey, Sarah B. ;
Capoferri, Adam A. ;
Lai, Jun ;
Strain, Matthew C. ;
Lada, Steven M. ;
Hoh, Rebecca ;
Ho, Ya-Chi ;
Richman, Douglas D. ;
Deeks, Steven G. ;
Siliciano, Janet D. ;
Siliciano, Robert F. .
NATURE MEDICINE, 2016, 22 (09) :1043-+
[5]   Broadly neutralizing anti-HIV-1 monoclonal antibodies in the clinic [J].
Caskey, Marina ;
Klein, Florian ;
Nussenzweig, Michel C. .
NATURE MEDICINE, 2019, 25 (04) :547-553
[6]   IN-VIVO FATE OF HIV-1-INFECTED T-CELLS - QUANTITATIVE-ANALYSIS OF THE TRANSITION TO STABLE LATENCY [J].
CHUN, TW ;
FINZI, D ;
MARGOLICK, J ;
CHADWICK, K ;
SCHWARTZ, D ;
SILICIANO, RF .
NATURE MEDICINE, 1995, 1 (12) :1284-1290
[7]   Quantification of latent tissue reservoirs and total body viral load in HIV-1 Infection [J].
Chun, TW ;
Carruth, L ;
Finzi, D ;
Shen, XF ;
DiGiuseppe, JA ;
Taylor, H ;
Hermankova, M ;
Chadwick, K ;
Margolick, J ;
Quinn, TC ;
Kuo, YH ;
Brookmeyer, R ;
Zeiger, MA ;
BarditchCrovo, P ;
Siliciano, RF .
NATURE, 1997, 387 (6629) :183-188
[8]   Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy [J].
Chun, TW ;
Stuyver, L ;
Mizell, SB ;
Ehler, LA ;
Mican, JAM ;
Baseler, M ;
Lloyd, AL ;
Nowak, MA ;
Fauci, AS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (24) :13193-13197
[9]   Precise Quantitation of the Latent HIV-1 Reservoir: Implications for Eradication Strategies [J].
Crooks, Amanda M. ;
Bateson, Rosalie ;
Cope, Anna B. ;
Dahl, Noelle P. ;
Griggs, Morgan K. ;
Kuruc, JoAnn D. ;
Gay, Cynthia L. ;
Eron, Joseph J. ;
Margolis, David M. ;
Bosch, Ronald J. ;
Archin, Nancie M. .
JOURNAL OF INFECTIOUS DISEASES, 2015, 212 (09) :1361-1365
[10]   Comparative Analysis of Measures of Viral Reservoirs in HIV-1 Eradication Studies [J].
Eriksson, Susanne ;
Graf, Erin H. ;
Dahl, Viktor ;
Strain, Matthew C. ;
Yukl, Steven A. ;
Lysenko, Elena S. ;
Bosch, Ronald J. ;
Lai, Jun ;
Chioma, Stanley ;
Emad, Fatemeh ;
Abdel-Mohsen, Mohamed ;
Hoh, Rebecca ;
Hecht, Frederick ;
Hunt, Peter ;
Somsouk, Ma ;
Wong, Joseph ;
Johnston, Rowena ;
Siliciano, Robert F. ;
Richman, Douglas D. ;
O'Doherty, Una ;
Palmer, Sarah ;
Deeks, Steven G. ;
Siliciano, Janet D. .
PLOS PATHOGENS, 2013, 9 (02)